BARACLUDE
entecavir
- Strength
- .5 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
E.R. Squibb & Sons, L.L.C.
Listed by EPIC PHARMA, LLC
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 42806-659 |
| FDA application | ANDA212126 |
| RxNorm concept | 485434 |
| Package sizes listed | 1 |
| Marketed since | June 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
entecavir
E.R. Squibb & Sons, L.L.C.
entecavir
E.R. Squibb & Sons, L.L.C.
entecavir
E.R. Squibb & Sons, L.L.C.
NorthStar RxLLC
Epic Pharma, LLC
Yaopharma Co., Ltd.
Amneal Pharmaceuticals LLC
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.